SIM
FOMX

Strategic Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Strategic Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,151
Closed -$66K – 143
2014
Q3 		$66K Buy
+12,151
New +$69.8K 0.02% 100

Other funds holding FOMX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Strategic Investment Management's FOMX Position: Q4 2014 in Review

Strategic Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2014, closing a stake of 12,151 shares — an estimated $66K sold.

Strategic Investment Management first reported a position in FOMX in Q3 2014 and held it in 1 quarter. The position peaked at $66K in Q3 2014. 21 funds tracked by Wall St. Rank hold FOMX as of Q4 2014.

  • Strategic Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2014 after selling out during the quarter.
  • Strategic Investment Management sold 12,151 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2014, an estimated $66K.
  • Strategic Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 1 quarter.
  • Strategic Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $66K in Q3 2014.
  • 21 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2014.

Based on Strategic Investment Management's 13F filing for Q4 2014, filed 13 Feb 2015.